Statera Biopharma Ownership 2024 | Who Owns Statera Biopharma Now?

Institutional Ownership

0.00%

Institutional Holders

1.00

Statera Biopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	100.00%	-	211,836	-223,026	-51.29%	3,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.70%	-	1,000	-	-	18,000	Mar 31, 2023
IFP ADVISORS, INC	0.06%	-	87	-500	-85.18%	271,000	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-24,494	-100.00%	-	Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC	-	-	-	-17,000	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-60	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,011	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-28,325	-100.00%	-	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30,000	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-100	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-81,303	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-287	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-171,110	-100.00%	-	Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/	-	-	-	-61,200	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-68,247	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-722,390	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-29,967	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-130,774	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-378,677	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-58,579	-100.00%	-	Mar 31, 2023

Statera Biopharma's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 100.00% of the company's total share outstanding, currently valued at $3.00K. The top 10 institutional shareholders own together 100.76% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ACADIAN ASSET MANAGEMENT LLC	100.00%	-	211,836	-223,026	-51.29%	3,000	Mar 31, 2023
IFP ADVISORS, INC	0.06%	-	87	-500	-85.18%	271,000	Mar 31, 2023
TUCKER ASSET MANAGEMENT LLC	0.70%	-	1,000	-	-	18,000	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-24,494	-100.00%	-	Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC	-	-	-	-17,000	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-60	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,011	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-28,325	-100.00%	-	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30,000	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-100	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-81,303	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-287	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-171,110	-100.00%	-	Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/	-	-	-	-61,200	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-68,247	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-722,390	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-29,967	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-130,774	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-378,677	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-58,579	-100.00%	-	Mar 31, 2023

The largest Statera Biopharma shareholder by % of total assets is ACADIAN ASSET MANAGEMENT LLC. The company owns 211.84K shares of Statera Biopharma (STAB), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TUCKER ASSET MANAGEMENT LLC	0.70%	-	1,000	-	-	18,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-60	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-100	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-287	-100.00%	-	Mar 31, 2023
ARCHER INVESTMENT CORP	-	-	-	-300	-100.00%	-	Mar 31, 2023
IFP ADVISORS, INC	0.06%	-	87	-500	-85.18%	271,000	Mar 31, 2023
NATIONAL BANK OF CANADA /FI/	-	-	-	-1,000	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,011	-100.00%	-	Mar 31, 2023
UNITED CAPITAL MANAGEMENT OF KS, INC.	-	-	-	-15,000	-100.00%	-	Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC	-	-	-	-17,000	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-24,494	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-28,325	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-29,967	-100.00%	-	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30,000	-100.00%	-	Mar 31, 2023
CI PRIVATE WEALTH, LLC	-	-	-	-43,350	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-58,579	-100.00%	-	Mar 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-59,825	-100.00%	-	Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/	-	-	-	-61,200	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-68,247	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-81,303	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Statera Biopharma's largest institutional buyer is TUCKER ASSET MANAGEMENT LLC. The company purchased 0.00 stocks of STAB, valued at $18.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-722,390	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-378,677	-100.00%	-	Mar 31, 2023
ACADIAN ASSET MANAGEMENT LLC	100.00%	-	211,836	-223,026	-51.29%	3,000	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-171,110	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-130,774	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-109,531	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-81,303	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-68,247	-100.00%	-	Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/	-	-	-	-61,200	-100.00%	-	Mar 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-59,825	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-58,579	-100.00%	-	Mar 31, 2023
CI PRIVATE WEALTH, LLC	-	-	-	-43,350	-100.00%	-	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30,000	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-29,967	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-28,325	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-24,494	-100.00%	-	Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC	-	-	-	-17,000	-100.00%	-	Mar 31, 2023
UNITED CAPITAL MANAGEMENT OF KS, INC.	-	-	-	-15,000	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,011	-100.00%	-	Mar 31, 2023
NATIONAL BANK OF CANADA /FI/	-	-	-	-1,000	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Statera Biopharma's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -0.72M shares of STAB, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-722,390	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-378,677	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-171,110	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-130,774	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-109,531	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-81,303	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-68,247	-100.00%	-	Mar 31, 2023
PRICE T ROWE ASSOCIATES INC /MD/	-	-	-	-61,200	-100.00%	-	Mar 31, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	-	-	-	-59,825	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-58,579	-100.00%	-	Mar 31, 2023
CI PRIVATE WEALTH, LLC	-	-	-	-43,350	-100.00%	-	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-30,000	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-29,967	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-28,325	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-24,494	-100.00%	-	Mar 31, 2023
BELL & BROWN WEALTH ADVISORS, LLC	-	-	-	-17,000	-100.00%	-	Mar 31, 2023
UNITED CAPITAL MANAGEMENT OF KS, INC.	-	-	-	-15,000	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-2,011	-100.00%	-	Mar 31, 2023
NATIONAL BANK OF CANADA /FI/	-	-	-	-1,000	-100.00%	-	Mar 31, 2023
ARCHER INVESTMENT CORP	-	-	-	-300	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-287	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	-	-	-	-100	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-60	-100.00%	-	Mar 31, 2023

Statera Biopharma's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.72M shares, valued at -, as of undefined.

Statera Biopharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	28,249	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.00%	378,677	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	114,324	-	-	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	12,170	-	-	Feb 29, 2024
SUNAMERICA SERIES TRUST	0.00%	61,200	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	108,153	-	-	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	4,523	-	-	Dec 31, 2023

Statera Biopharma's largest mutual fund holder by % of total assets is "VANGUARD INSTITUTIONAL INDEX FUNDS", owning 28.25K shares, compromising 0.00% of its total assets.

Statera Biopharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	1	-
30 Jun, 23	1	-66.67%
31 Mar, 23	3	-88.46%
31 Dec, 22	26	4.00%
30 Sep, 22	25	-3.85%
30 Jun, 22	26	-
31 Mar, 22	26	-
31 Dec, 21	26	36.84%
30 Sep, 21	19	-

As of 31 Dec 23, 1 institutions are holding Statera Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	1,000	-
30 Jun, 23	1,000	-99.53%
31 Mar, 23	212,923	-91.38%
31 Dec, 22	2,470,279	-16.21%
30 Sep, 22	2,948,266	-1.77%
30 Jun, 22	3,001,444	40.83%
31 Mar, 22	2,131,230	4.92%
31 Dec, 21	2,031,198	68.47%
30 Sep, 21	1,205,693	-

Statera Biopharma (STAB) has 1.00K shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	0.00%	-
30 Jun, 23	0.00%	1.11%
31 Mar, 23	0.42%	1.75%
31 Dec, 22	4.92%	14.28%
30 Sep, 22	5.87%	16.07%
30 Jun, 22	6.04%	19.47%
31 Mar, 22	5.57%	16.65%
31 Dec, 21	5.79%	29.09%
30 Sep, 21	4.46%	-

As of 31 Dec 23, Statera Biopharma is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	1	-
30 Jun, 23	-	-
31 Mar, 23	-	-100.00%
31 Dec, 22	11	83.33%
30 Sep, 22	6	-33.33%
30 Jun, 22	9	-47.06%
31 Mar, 22	17	-15.00%
31 Dec, 21	20	5.26%
30 Sep, 21	19	-

1 institutional shareholders have increased their position in STAB stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	2	-71.43%
31 Dec, 22	7	16.67%
30 Sep, 22	6	-
30 Jun, 22	6	20.00%
31 Mar, 22	5	150.00%
31 Dec, 21	2	-
30 Sep, 21	-	-

- institutional shareholders have reduced their position in STAB stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	1	-	1,000	-	0.00%	-	1	-	-	-
30 Jun, 23	1	-66.67%	1,000	-99.53%	0.00%	1.11%	-	-	-	-100.00%
31 Mar, 23	3	-88.46%	212,923	-91.38%	0.42%	1.75%	-	-100.00%	2	-71.43%
31 Dec, 22	26	4.00%	2,470,279	-16.21%	4.92%	14.28%	11	83.33%	7	16.67%
30 Sep, 22	25	-3.85%	2,948,266	-1.77%	5.87%	16.07%	6	-33.33%	6	-
30 Jun, 22	26	-	3,001,444	40.83%	6.04%	19.47%	9	-47.06%	6	20.00%
31 Mar, 22	26	-	2,131,230	4.92%	5.57%	16.65%	17	-15.00%	5	150.00%
31 Dec, 21	26	36.84%	2,031,198	68.47%	5.79%	29.09%	20	5.26%	2	-
30 Sep, 21	19	-	1,205,693	-	4.46%	-	19	-	-	-

Statera Biopharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jul 23, 2021	Miller Langdon L	officer	Chief Medical Officer	M-Exempt	Sell	10,000	$3.00	$30.00K	-
Dec 23, 2019	Zosh Christopher	officer	Vice President of Finance		Sell	300	$3.20	$960.00	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 21, 2022	Chandrasekhar Satishchandran	director			Buy	-	-	-	-
Oct 28, 2021	SALUCK RANDY S.	director	-	A-Award	Buy	60,000	-	-	60,140
Oct 19, 2021	Barbarick Steve K	director	-	A-Award	Buy	60,000	-	-	60,000
Oct 19, 2021	Verny Lea	director	-	A-Award	Buy	60,000	-	-	60,000
Sep 30, 2021	Markvicka Taunia	director, officer	Chief Operating Officer	A-Award	Buy	100,000	-	-	100,000
Aug 04, 2021	Handley Michael K	director, officer	President and CEO	A-Award	Buy	296,609	-	-	296,609
Aug 04, 2021	Handley Michael K	director, officer	President and CEO		Buy	-	-	-	-
Jul 29, 2021	Buckheit Robert	officer	Chief Technology Officer	A-Award	Buy	24,378	-	-	24,378
Jul 29, 2021	Selsky Clifford	officer	Chief Medical Officer	A-Award	Buy	101,579	-	-	101,579
Jul 29, 2021	McAvoy Cozette M.	officer	Chief Legal Officer	A-Award	Buy	60,947	-	-	60,947
Jul 29, 2021	ARONSTAM PETER	officer	Chief Financial Officer	A-Award	Buy	141,370	-	-	141,370
Jul 29, 2021	Buckheit Robert	officer	-		Buy	-	-	-	-
Jul 29, 2021	Selsky Clifford	officer	-		Buy	-	-	-	-
Jul 29, 2021	ARONSTAM PETER	officer	-		Buy	-	-	-	-
Jul 29, 2021	Barbarick Steve K	director			Buy	-	-	-	-
Jul 29, 2021	McAvoy Cozette M.	officer	-		Buy	-	-	-	-
Jul 29, 2021	Markvicka Taunia	director, officer	Chief Operating Officer		Buy	-	-	-	-
Jul 23, 2021	Miller Langdon L	officer	Chief Medical Officer	M-Exempt	Buy	10,000	$3.00	$30.00K	10,000
Jul 23, 2021	Miller Langdon L	officer	Chief Medical Officer	M-Exempt	Sell	10,000	$3.00	$30.00K	-
Dec 23, 2019	Zosh Christopher	officer	Vice President of Finance		Sell	300	$3.20	$960.00	-

The last insider sell of Statera Biopharma's stock was made by Miller Langdon L on Jul 23 2021, selling 10,000 shares at $3.00 per share (valued at $30.00K).

Statera Biopharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2022	-	-	-
Q3 2021	10	1	1000.00%
Q3 2018	-	-	-
Q2 2017	-	6	-
Q3 2016	-	4	-
Q2 2016	-	-	-
Q3 2015	-	2	-
Q2 2015	10	-	-
Q1 2015	4	-	-
Q4 2014	-	-	-
Q3 2014	1	1	100.00%
Q2 2014	10	2	500.00%
Q1 2014	5	-	-
Q2 2013	21	2	1050.00%
Q1 2013	1	-	-
Q4 2012	2	1	200.00%
Q3 2012	2	-	-
Q2 2012	14	-	-
Q1 2012	8	3	266.67%
Q4 2011	9	-	-

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Statera Biopharma's insiders, as of Q1 2022.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2022	-	-	-
Q3 2021	-	-	-
Q3 2018	-	-	-
Q2 2017	-	-	-
Q3 2016	-	-	-
Q2 2016	-	-	-
Q3 2015	-	-	-
Q2 2015	-	-	-
Q1 2015	1	-	-
Q4 2014	-	-	-
Q3 2014	-	-	-
Q2 2014	-	-	-
Q1 2014	-	-	-
Q2 2013	2	-	-
Q1 2013	1	-	-
Q4 2012	-	-	-
Q3 2012	2	-	-
Q2 2012	2	-	-
Q1 2012	4	3	133.33%
Q4 2011	5	-	-

As of Q1 2022, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Statera Biopharma's stocks.

Statera Biopharma Peer Ownership

Ticker	Company
SILO	Silo Pharma, Inc.
KROS	Keros Therapeutics, Inc.
ELYM	Eliem Therapeutics, Inc.
AADI	Aadi Bioscience, Inc.
AVTE	Aerovate Therapeutics, Inc.
ACRV	Acrivon Therapeutics, Inc. Common Stock
ALEC	Alector, Inc.

STAB Ownership FAQ

Who Owns Statera Biopharma?

Statera Biopharma is owned by institutional shareholders (0.00%), insiders (0.00%), and public (100.00%). The largest institutional shareholder of Statera Biopharma is ACADIAN ASSET MANAGEMENT LLC (100.00% of total shares) and the top mutual fund owner is VANGUARD INSTITUTIONAL INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Statera Biopharma?

Statera Biopharma's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, TUCKER ASSET MANAGEMENT LLC, IFP ADVISORS, INC, HRT FINANCIAL LP, and BELL & BROWN WEALTH ADVISORS, LLC. The top five shareholders own together 100.76% of the company's share outstanding.

How many Statera Biopharma shareholders are there?

As of Dec 2023, there are 1 institutional shareholders of Statera Biopharma.

What percentage of Statera Biopharma is owned by ACADIAN ASSET MANAGEMENT LLC?

ACADIAN ASSET MANAGEMENT LLC owns 211.84K shares of Statera Biopharma, representing 100.00% of the company's total shares outstanding, valued at $3K (as of Mar 2023).

What percentage of Statera Biopharma is owned by TUCKER ASSET MANAGEMENT LLC?

As of Mar 2023, TUCKER ASSET MANAGEMENT LLC holds 1K shares of Statera Biopharma (STAB), compromising 0.70% of the company, valued at $18K.

What percentage of Statera Biopharma is owned by IFP ADVISORS, INC?

IFP ADVISORS, INC is the third largest holder of Statera Biopharma. The company owns 87 of the company's shares outstanding (worth $271K).